A continuous hormone monitoring sensor that enables personalized drug and treatment development tailored to female unique health needs.
Female participation in clinical trials is often limited due to the influence of the reproductive cycle on results. This leads to a limited understanding of medication responses and treatment outcomes, as most data is based on male-centered studies. Without this knowledge, truly personalized medicine for females is unattainable.
Misslaboratory's sensor enables physiological data collection across all phases of the reproductive cycle, supporting the development of new pharmaceuticals and optimized treatment methods. It minimizes patient invasiveness, reduces the impact of stress and pain on results, and aims to help increase the success rate of artificial insemination.
Company Details
- Founded
- -
- Address
- Vilnius, Lt
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- https://misslaboratory.com/
- Keywords
- Medical, Technology, Business, Regulatory.
- HQ
- Vilnius
Misslaboratory Questions
Misslaboratory's website is https://misslaboratory.com/
Misslaboratory's LinkedIn profile is https://lt.linkedin.com/company/misslaboratory
Misslaboratory's industry is
Hospitals and Health Care
Misslaboratory's top competitors are
Fitodenta,
Astrazeneca,
Brightverse, Mb,
Biosure,
Center For Physical Sciences And Technology (Ftmc),
Antalgija,
Atrandi Biosciences,
Upwood.io,
Hornet Therapeutics,
Utero Diagnostics.
Misslaboratory's categories are Hospitals and Health Care
Misslaboratory's founding year is 2025
